We advised Signify Health on its IPO and NYSE listing

Davis Polk advised Signify Health, Inc. on its $648.6 million initial public offering of 27,025,000 shares of Class A common stock, including 3,525,000 shares purchased pursuant to the full exercise of the underwriters’ over-allotment option. The shares of Class A common stock are listed on the New York Stock Exchange under the symbol “SGFY.”

Signify Health is a leading healthcare platform that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs. Its solutions support value-based payment programs by aligning financial incentives around outcomes, providing tools to health plans and healthcare organizations designed to assess and manage risk and identify actionable opportunities for improved patient outcomes, coordination and cost-savings. 

The Davis Polk capital markets team included partners Shane Tintle and Deanna L. Kirkpatrick and associates Hillary A. Coleman, S. Elizabeth Kim and Alexander Kraik. The executive compensation team included partner Jeffrey P. Crandall and associate Charlotte R. Fabiani. The tax team included partner William A. Curran and associates Elina Khodorkovsky and Kendra Simpson. All members of the Davis Polk team are based in the New York office.